Columbia Care Announces National Launch of the CNC Card – the Nation’s First Cannabis Industry Credit Card

Columbia Care Inc. (NEO:CCHW, OTC:COLXF) (“Columbia Care” or the “Company”), one of the largest multistate operators in the medical cannabis industry, with licenses in 15 jurisdictions in the US and the EU, today announced that it is launching its Columbia National Credit program (the “CNC Card”) across the United States, following a successful pilot program in New York. With this program, Columbia Care becomes the first and only cannabis company in the United States capable of directly accepting a credit card for cannabis purchases.

Recent expansion of the program into the Company’s Delaware and Pennsylvania markets from New York will be followed later this month by availability in Illinois and Arizona, with expansion to all Columbia Care locations by the end of 2019. Available initially at Columbia Care dispensaries exclusively, the Company is evaluating opportunities through targeted partnerships for broader market adoption as the premier and only credit payment option available to the cannabis industry.

“We are in the business of expanding the entire national cannabis market, and this is exactly the type of industry-wide challenge our team excels at solving. By launching the first credit card in the country that can be used by consumers and industry participants to purchase cannabis products, we now exclusively offer an important capability that will serve Columbia Care’s national growth initiatives, including home delivery, automatic fulfillment and e-commerce,” said Nicholas Vita, chief executive officer of Columbia Care. “If given the choice to pay with credit or cash, consumers prefer credit, and until now, the cannabis industry has been predominantly cash-based due to restrictions on the use of credit cards for cannabis purchases. Through our exclusive network of partners and painstaking attention to detail, we successfully navigated the complexities of the financial industry unique to cannabis and are proud to once again lead the way as the first company to solve this fundamental issue. Through the launch of the CNC Card, we seek to further differentiate our customers’ experience by making their journey as easy and familiar as possible, reaffirming Columbia Care’s commitment to delivering innovative solutions designed to enhance the patient experience, build customer loyalty and provide greater access to our high-quality portfolio of products.”

The Company initially launched the CNC Card as a pilot program in New York in the second half of 2018 and experienced an 18% increase in average basket size for in-store purchases using the CNC Card over other forms of payment, in addition to significant increases in repeat visits and an increased utilization rate for home delivery and automatic fulfillment. Home delivery in New York currently represents over 10% of the Company’s revenue in the state, with an average basket size 40% greater than those in-store. Upon introducing the CNC Card in New York, home delivery users became the fastest growing segment of the CNC program, increasing 25% month-over-month in 2019.

“We are encouraged by the overall results of our pilot program and the impact it has had on our home delivery customers, who are often unable to visit our dispensaries for a variety of reasons,” continued Vita. “Based on our success in New York, one of the most demanding retail markets in the world, we are confident that the CNC Card has the potential to be a significant value add for the company and for all of our customers who look to us for reliable and convenient high-quality health and wellness options.”

In addition to its utility as a dependable, electronic form of payment, CNC cardmembers may also be eligible for other benefits including cash back affinity programs, discounts, educational seminars, first access to new products and other exclusive offers. More information can be found at www.columbianationalcredit.com.

About Columbia Care Inc.

Columbia Care Inc. (“Columbia Care” or the “Company”) is one of the largest and most experienced multi-state operators in the medical cannabis industry, with licenses in 15 jurisdictions in the US and the EU. With over 1,000,000 successful sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect. For more information on Columbia Care, please visit www.col-care.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190613005297/en/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Search CannabisFN

Press Coverage

Psychedelics Index

Top Videos

Tim Seymour of Seymour Asset Management

Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms.  Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses.   Tim remains a recognized voice within the investment community […]

Michael Berger of Technical 420

Technical420 is the premier provider of research and analysis on cannabis stocks.  We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry.  “Our research is our passion!”  Your profit is our reward!

Resolve Digital Health Inc.

Resolve Digital Health Inc. committed to establishing a standard of care missing from the medical cannabis industry until now.

Sublime Canna Inc.

Sublime is a California leader in cannabis manufacturing and distribution.

Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer